Condition: Atrial Fibrillation · Sponsor: Saint Antoine University Hospital
The aim of the present prospective study is to further develop and validate a composite risk score predicting both ischemic and bleeding risk, based on epidemiologic, clinical, biological, and/or morphologic complementary data. First, the investigators will assess the predictive performance of current clinical risk scores. Second, the investigators will assess the potential predictive value of additional markers. Third, the investigators will aim to develop a new risk score.
This description comes directly from the study's public registry record.
Ariel Cohen, MD, PhD · +33149282886 · ariel.cohen@aphp.fr
Sylvie Lang, PhD · +33689742859 · sylvie.lang@aphp.fr
Always discuss trial participation with your own doctor first.
| Service de cardiologie - hôpital Saint Antoine | Paris, France | Recruiting |
| Service de cadiologie - Hôpital Pitié Salpêtrière | Paris, France | Suspended |
| Centre Cardiologique du Nord | Saint-Denis, France | Recruiting |
| Service de cardiologie - Clinique Pasteur | Toulouse, France | Suspended |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02741349